Back to Authors

Allen, Laura A.

A5020197895 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 20

IC‐P‐065: ANALYSIS OF IOFLUPANE‐SPECT FINDINGS USING DATQUANT IN PATIENTS WITH IDIOPATHIC REM SLEEP BEHAVIOR DISORDER

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_1 | Pages: No page available

10.1016/j.jalz.2019.06.4908

IC‐P‐064: ANALYSIS OF IOFLUPANE‐SPECT FINDINGS USING DATQUANT IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_1 | Pages: No page available

10.1016/j.jalz.2019.06.4907

O4‐03‐03: CLINICAL CHARACTERIZATION OF MILD COGNITIVE IMPAIRMENT ASSOCIATED WITH EVENTUAL LEWY BODY DISEASE PATHOLOGY

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_23 | Pages: No page available

10.1016/j.jalz.2019.06.4754

P4‐267: ANALYSIS OF IOFLUPANE‐SPECT FINDINGS USING DATQUANT IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_26 | Pages: No page available

10.1016/j.jalz.2019.06.3936

P3‐411: ANALYSIS OF IOFLUPANE‐SPECT FINDINGS USING DATQUANT IN PATIENTS WITH IDIOPATHIC REM SLEEP BEHAVIOR DISORDER

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_21 | Pages: No page available

10.1016/j.jalz.2019.06.3445

P1‐367: COMPARISON OF IOFLUPANE‐SPECT FINDINGS USING DATQUANT IN PATIENTS WITH ALZHEIMER'S DISEASE DEMENTIA AND DEMENTIA WITH LEWY BODIES

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2019.06.922

Clinicopathological and 123I‐FP‐CIT SPECT correlations in patients with dementia

Annals of Clinical and Translational Neurology | January 24, 2018 | Volume: 5 | Issue: 3 | Pages: 376-381

10.1002/acn3.521 | PMID 29560382

AbstractThe relationship between clinicopathologic diagnosis and 123I‐FP‐CIT SPECT in 18 patients with dementia (12 with Lewy body disease) from one center in the United States was assessed. The sensitivity and specificity of abnormal 123I‐FP‐CIT SPECT with reduced striatal uptake on visual inspection for predicting Lewy body disease were 91.7% and 83.3%, respectively. The mean calculated putamen to occipital ratio (mPOR) based on regions of interest was significantly reduced in Lewy body disease compared to non‐Lewy body disease cases (P = 0.002). In this study, abnormal 123I‐FP‐CIT SPECT was strongly associated with underlying Lewy body disease pathology, supporting the utility of 123I‐FP‐CIT SPECT in the clinical diagnosis of dementia with Lewy bodies.
P2‐285: Characteristics, caregiver evaluations, and telephone call volume of a frontotemporal dementia caregiver educational and support program

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_13 | Pages: No page available

10.1016/j.jalz.2015.06.826

P2–119: Superficial siderosis with predominant frontal lobe deposition in a person with Lewy body dementia

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_10 | Pages: No page available

10.1016/j.jalz.2013.05.763

P4–086: Dramatic improvement with donepezil in a case of dementia with Lewy bodies

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_18 | Pages: No page available

10.1016/j.jalz.2013.05.1475